A novel mitochondrial-related signature to decode tumor immunity and predict survival in chromophobe renal cell carcinoma
{{output}}
Chromophobe renal cell carcinoma (chRCC) comprises about 5%-10% of all renal cancer cases, some of which are aggressive and metastatic. Mitochondria are significantly activated in chRCC, however, a risk model based on mitochondrial-related genes for chRCC has ... ...
